Table 4 Patient consumption profile and Human Health benefit and burden results
1. Patient consumption profile | TI | PP1M | PP3M |
|---|---|---|---|
Syringes (1 M) | – | 8055 | 94 |
Syringes (3 M) | – | – | 2564 |
GP visits | 2883 | 3322 | 3447 |
Psychiatrist visits | 34,109 | 35,224 | 35,528 |
Ambulatory care visits | 1849 | 701 | 371 |
General hospital bed days | 791 | 335 | 178 |
Psychiatric hospital bed days | 43,864 | 16,406 | 8699 |
2. Human Health benefit | |||
Years Lived with Disability (YLD) | |||
Total patient YLDs | 626.80 | 603.49 | 596.90 |
ΔYLDs of treatment vs. TI (%) | – | −23.31 (−3.72%) | −29.91 (−4.77%) |
Years of Life Lost (YLL) | |||
Total patient YLLs | 346.23 | 300.63 | 288.36 |
ΔYLL of treatment vs. TI (%) | – | −45.60 (−13.17%) | −57.87 (−16.71%) |
Disability-Adjusted Life Years (DALY) = YLD + YLL | |||
Total patient DALYs | 973.03 | 904.12 | 885.26 |
ΔDALY of treatment vs. TI (%) | – | −68.91 (−7.08%) | −87.77 (−9.02%) |
Quality-Adjusted Life Years (QALY) | |||
Total patient QALYs | 785.22 | 830.54 | 881.35 |
ΔQALY of treatment vs. TI (%) | – | + 45.32 (+ 5.77%) | + 96.13 (+ 12.24%) |
3. Human Health burden | |||
Environmental DALYs | |||
Total environmental DALYs | 0.954 | 0.579 | 0.468 |
ΔDALYs of treatment vs. TI (%) | – | −0.375 (−39.32%) | −0.487 (−51.00%) |
4. Net Human Health effects (net DALYs = YLD + YLL + environmental DALYs) | |||
Total net DALYs | 973.98 | 904.70 | 885.73 |
ΔDALY of treatments vs. TI | – | −69.29 (−7.11%) | −88.26 (−9.06%) |